Improved antitumor activity and tolerability of cabazitaxel derived remote-loading liposomes
Author:
Publisher
Elsevier BV
Subject
Pharmaceutical Science
Reference39 articles.
1. Cabazitaxel for the treatment of castration-resistant prostate cancer;Agarwal;Future Oncol.,2011
2. Doxil(R)–the first FDA-approved nano-drug: lessons learned;Barenholz;J. Control. Release,2012
3. Serum-stable, long-circulating paclitaxel-loaded colloidal carriers decorated with a new amphiphilic PEG derivative;Basile;Int. J. Pharm.,2012
4. Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer;Batist;J. Clin. Oncol.,2001
5. New drug candidates for liposomal delivery identified by computer modeling of liposomes' remote loading and leakage;Cern;J. Control. Release,2017
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Anti-EGFR immunoliposomes for cabazitaxel delivery: From formulation development to in vivo evaluation in prostate cancer xenograft model;International Journal of Pharmaceutics;2024-08
2. “Transforming enemy into friend” strategy-based stimuli responsive dual-drug liposomes for synergistic chemo-photodynamic therapy;Chemical Engineering Journal;2024-05
3. Formulation and evaluation of a two-stage targeted liposome coated with hyaluronic acid for improving lung cancer chemotherapy and overcoming multidrug resistance;Journal of Biomaterials Science, Polymer Edition;2023-04-22
4. Cabazitaxel-nano delivery systems as a cutting-edge for cancer therapy;Journal of Drug Delivery Science and Technology;2023-04
5. Nanocarriers for delivery of taxanes: A review on physicochemical and biological aspects;Journal of Drug Delivery Science and Technology;2023-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3